Autres langues EXOPHARM

Actions

EX1

AU0000030975

Marché Fermé - Australian S.E. Autres places de cotation 02:10:45 02/10/2023			Varia. 5j.	Varia. 1 janv.
0,0275 ^AUD	+10,00%		-.--%	-.--%

01/05	Tryp Therapeutics Inc. (CNSX:TRYP) a finalisé l'acquisition d'Exopharm Limited (ASX:EX1) dans le cadre d'une opération de fusion inversée.	CI
26/02	Exopharm Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tryp Therapeutics Inc. completed the acquisition of Exopharm Limited in a reverse merger transaction.	01/05
Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Exopharm to Cut CEO Role Amid Cost Reductions	28/11
Exopharm Limited Announces Ian Dixon's Employment as CEO Expects to End in Early Calendar Year 2024	27/11
Exopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29/08/23
Exopharm Limited Announces Executive Changes	22/06/23
Exopharm Achieves Initial Success With Exosome Products; Shares Fall 21%	28/04/23
Exopharm Secures R&D Cash Loan Advance from Radium Capital	09/03/23
Exopharm Limited announced that it has received AUD 1 million in funding	09/03/23
Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2022	26/02/23
Exopharm Limited Announces Board Changes	22/02/23
Exopharm Limited announced that it expects to receive AUD 0.6 million in funding	13/02/23
Exopharm Limited Announces Resignation of Elizabeth McGregor as Non-Executive Director	20/12/22
Sartorius BIA Separations and Exopharm Ltd Testing the Synergy of Exopharm's Patented LEAP Technology Together with Bia's Unique Cim (Convective Interaction Media) Monolith Chromatography for Improved Large- Scale Exosome Production and Commercialization	16/11/22
Exopharm Limited Will Commence LEAP Technology Transfer to AIRM under MSA	13/11/22
Exopharm Receives $2.6 Million R&D Tax Rebate	27/10/22
Exopharm Says Drug Product Safe After Animal Testing	28/09/22
Exopharm Limited Announces Study Results Indicate Exosomes Safe for Clinical Pursuit	28/09/22
Exopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/08/22
Exopharm Limited Auditor Raises 'Going Concern' Doubt	30/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues EXOPHARM

Actions

EX1

AU0000030975

Autres langues

Filtres